| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
3,280,000 |
| Market
Cap: |
1.13(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.3437 - $1.46 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Longeveron is a clinical stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions. Co.'s primary investigational product is the LOMECEL-B™ cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. Co. is sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome, and hypoplastic left heart syndrome.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
322,872 |
322,872 |
| Total Buy Value |
$0 |
$0 |
$734,301 |
$734,301 |
| Total People Bought |
0 |
0 |
6 |
6 |
| Total Buy Transactions |
0 |
0 |
9 |
9 |
| Total Shares Sold |
1,250 |
1,250 |
1,250 |
44,782 |
| Total Sell Value |
$2,588 |
$2,588 |
$2,588 |
$169,729 |
| Total People Sold |
1 |
1 |
1 |
3 |
| Total Sell Transactions |
1 |
1 |
1 |
5 |
| End Date |
2024-09-26 |
2024-06-25 |
2023-12-26 |
2022-12-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Baluch Khoso |
|
– • – |
2024-12-02 |
4 |
S |
$2.07 |
$2,588 |
D/D |
(1,250) |
23,750 |
|
- |
|
| Locklear Lisa |
Chief Financial Officer |
• – – |
2024-10-01 |
4 |
D |
$1.88 |
$9,994 |
D/D |
(5,316) |
158,315 |
|
- |
|
| Agafonova Nataliya |
Chief Medical Officer |
• – – |
2024-10-01 |
4 |
D |
$1.88 |
$9,994 |
D/D |
(5,316) |
157,814 |
|
- |
|
| Hashad Mohamed Wael Ahmed |
Chief Executive Officer |
• – – |
2024-10-01 |
4 |
D |
$1.88 |
$25,111 |
D/D |
(13,357) |
278,261 |
|
- |
|
| Lehr Paul T |
General Counsel, Secretary |
• – – |
2024-10-01 |
4 |
D |
$1.88 |
$1,861 |
D/D |
(990) |
159,554 |
|
- |
|
| Ungaro Ursula |
|
– • – |
2024-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
23,500 |
24,000 |
|
- |
|
| Hare Neil E |
|
– • – |
2024-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
23,500 |
29,352 |
|
- |
|
| Baluch Khoso |
|
– • – |
2024-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
23,500 |
38,375 |
|
- |
|
| Soffer Rock |
|
– • – |
2024-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
23,500 |
232,034 |
|
- |
|
| Locklear Lisa |
Chief Financial Officer |
• – – |
2024-08-15 |
4 |
D |
$2.46 |
$34,526 |
D/D |
(14,035) |
163,631 |
|
- |
|
| Locklear Lisa |
Chief Financial Officer |
• – – |
2024-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
174,750 |
177,666 |
|
- |
|
| Hare Joshua |
Chief Scientific Officer |
• • • |
2024-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
93,766 |
727,046 |
|
- |
|
| Lehr Paul T |
General Counsel, Secretary |
• – – |
2024-08-15 |
4 |
D |
$2.46 |
$77,502 |
D/D |
(31,505) |
288,709 |
|
- |
|
| Lehr Paul T |
General Counsel, Secretary |
• – – |
2024-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
178,133 |
320,214 |
|
- |
|
| Agafonova Nataliya |
Chief Medical Officer |
• – – |
2024-08-15 |
4 |
D |
$2.46 |
$35,402 |
D/D |
(14,391) |
163,130 |
|
- |
|
| Agafonova Nataliya |
Chief Medical Officer |
• – – |
2024-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
175,750 |
177,521 |
|
- |
|
| Hashad Mohamed Wael Ahmed |
Chief Executive Officer |
• – – |
2024-08-15 |
4 |
D |
$2.46 |
$96,550 |
D/D |
(39,248) |
90,368 |
|
- |
|
| Hashad Mohamed Wael Ahmed |
Chief Executive Officer |
• – – |
2024-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
311,250 |
330,866 |
|
- |
|
| Motwani Neha J. |
|
– • – |
2024-07-02 |
4 |
A |
$1.68 |
$26,880 |
D/D |
16,000 |
16,000 |
|
- |
|
| Hajjar Roger Joseph |
|
– • – |
2024-07-02 |
4 |
A |
$1.68 |
$26,880 |
D/D |
16,000 |
16,000 |
|
- |
|
| Locklear Lisa |
Chief Financial Officer |
• – – |
2024-07-01 |
4 |
D |
$1.57 |
$560 |
D/D |
(357) |
2,916 |
|
- |
|
| Baluch Khoso |
|
– • – |
2024-06-09 |
4 |
D |
$1.06 |
$133 |
D/D |
(125) |
14,875 |
|
- |
|
| Lehr Paul T |
General Counsel, Secretary |
• – – |
2024-06-03 |
4 |
D |
$1.04 |
$338 |
D/D |
(325) |
142,081 |
|
- |
|
| Kender Richard N |
|
– • – |
2024-05-10 |
4 |
A |
$1.46 |
$23,280 |
D/D |
16,000 |
16,000 |
|
- |
|
| Locklear Lisa |
Chief Financial Officer |
• – – |
2024-05-02 |
4 |
D |
$2.83 |
$1,160 |
D/D |
(410) |
3,273 |
|
- |
|
141 Records found
|
|
Page 1 of 6 |
|
|
